Who Owns Oculis Stock?
NASDAQ: OCSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 47.54%
- Held by insiders
- 3.53%
- Institutional holders
- 78
- Institutions 47.5%
- Insiders 3.5%
- Public and other 48.9%
Who owns Oculis stock?
Institutional investors own about 47.5% of Oculis's shares, spread across 78 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 3.53% of OCS.
The largest institutional holders are Eqt Fund Management S.a R.l. (11.99%), Gildi - Lifeyrissjodur (4.19%) and Aberdeen Group plc (3.72%). Together, the top 10 institutions control 32.8% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their OCS positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of OCS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Eqt Fund Management S.a R.l. | 6.95M | 11.99% | +17.8% |
| Gildi - Lifeyrissjodur | 2.43M | 4.19% | -0.7% |
| Aberdeen Group plc | 2.16M | 3.72% | +23.6% |
| Millennium Management Llc | 2.04M | 3.52% | +123.7% |
| Pivotal bioVenture Partners Investment Advisor, LLC | 1.51M | 2.60% | -10.4% |
| Citadel Advisors Llc | 987.20K | 1.70% | +512.1% |
| Braidwell LP | 834.18K | 1.44% | +100.0% |
| Perceptive Advisors Llc | 808.83K | 1.39% | +63.8% |
| Saturn V Capital Management LP | 684.88K | 1.18% | +32.5% |
| SR One Capital Management, LP | 641.02K | 1.11% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of OCS
| Fund | Shares | % Held |
|---|---|---|
| abrdn Healthcare Investors | 749.75K | 1.29% |
| abrdn Healthcare Opportunities Fund | 710.89K | 1.23% |
| abrdn World Healthcare Fund | 429.25K | 0.74% |
| abrdn Life Sciences Investors | 333.41K | 0.58% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 314.74K | 0.54% |
| Global Macro Absolute Return Advantage Portfolio | 109.99K | 0.19% |
| VANGUARD WHITEHALL FUNDS-Vanguard International Explorer Fund | 105.66K | 0.18% |
| HARTFORD MUTUAL FUNDS INC/CT-THE HARTFORD SMALL COMPANY FUND | 69.22K | 0.12% |
| ALPS ETF TRUST-ALPS Medical Breakthroughs ETF | 58.93K | 0.10% |
| HARTFORD SERIES FUND INC-HARTFORD SMALL COMPANY HLS FUND | 45.41K | 0.08% |
Frequently asked questions
Who is the largest shareholder of Oculis?
Eqt Fund Management S.a R.l. is the largest institutional shareholder of OCS, owning 11.99% of shares outstanding (6.95M shares) as of its latest 13F filing.
What percentage of Oculis is owned by institutions?
Institutions own about 47.5% of OCS shares and 49.3% of the public float.
How much of Oculis do insiders own?
Insiders, such as officers and directors, own about 3.53% of OCS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.